Vytorin Gets Better Report
Vytorin is one of our cholesterol lowering drugs and it took a lot of heat last year from the media after a study was released stating it didn’t work any better than generic drugs and may increase risk of other diseases.
This year, the FDA is retracting some of their previous opinions in the following release: Follow-up to the January 25, 2008 Early Communication about an Ongoing Data Review for Ezetimibe/Simvastatin (marketed as Vytorin), Ezetimibe (marketed as Zetia), and Simvastatin (marketed as Zocor)
The FDA is now recommending that patients should not stop taking Vytorin and the FDA does seem to believe that this drug may offer better LDL (bad cholesterol) reductions.
I am pretty certain the mainstream media that published so many articles on this drug’s potential harm will not put as much emphasis on this newest recommendation.
Am I being skeptical or realistic?
This year, the FDA is retracting some of their previous opinions in the following release: Follow-up to the January 25, 2008 Early Communication about an Ongoing Data Review for Ezetimibe/Simvastatin (marketed as Vytorin), Ezetimibe (marketed as Zetia), and Simvastatin (marketed as Zocor)
The FDA is now recommending that patients should not stop taking Vytorin and the FDA does seem to believe that this drug may offer better LDL (bad cholesterol) reductions.
I am pretty certain the mainstream media that published so many articles on this drug’s potential harm will not put as much emphasis on this newest recommendation.
Am I being skeptical or realistic?
posted by Anonymous at 5:35 AM
1 Comments:
Honestly though, when the media hypes the reports of the dangers of certain drugs, what percentage of the patients experiencing these harmful side effects are there really?
The media reads "death related to Pfizers new drug" and the report on that ad nauseum. Rarely do they report that a million people found relief from a complicated medical condition with out serious side effects.
Thats why there is the standard tag line, a person must weigh the risks versus the benefits before starting any medications, from baby aspirin up to Chemo.
Post a Comment
<< Home